C. Rankin

CD32B, the human inhibitory Fc-gamma receptor IIB, as a target for monoclonal antibody therapy of B-cell lymphoma.

Steve Burke, J. Stavenhagen, H. Inzunza, 2006, Blood.

Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptors.

J. Stavenhagen, Syd Johnson, S. Burke, 2007, Cancer research.

Characterization of the radish mitochondrialnad3/rps12 locus: analysis of recombination repeats and RNA editing

C. Makaroff, C. Rankin, Marc Cutright, 1996, Current Genetics.

Regulation of left-right patterning in mice by growth/differentiation factor-1

C. Rankin, Se-Jin Lee, A. Lawler, 2000, Nature Genetics.

CD 32 B , the human inhibitory Fc-receptor IIB , as a target for monoclonal antibody therapy of B-cell lymphoma

J. Stavenhagen, H. Inzunza, S. Burke, 2006 .

Enhancing the potency of therapeutic monoclonal antibodies via Fc optimization.

J. Stavenhagen, S. Burke, S. Koenig, 2008, Advances in enzyme regulation.

Facteur de differenciation en cours de croissance 14

C. Rankin, Se-Jin Lee, 1997 .